Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline

Hormones and Behavior

Volumn 45, Issue 1, 2004, Pages 23-30

  Culver, Kirsten E ^a   Szechtman, Henry ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Clorgyline; Hypophysectomy; Locomotion; Mouthing; Quinpirole; Rat; Sensitization

Indexed keywords

CLORGYLINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; IODINE; MONOAMINE OXIDASE INHIBITOR; PSYCHOSTIMULANT AGENT; QUINPIROLE; SIGMA OPIATE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG EFFECT; ENDOCRINE FUNCTION; ENZYME INHIBITION; HYPOPHYSECTOMY; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

EID: 0346460277     PISSN: 0018506X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2003.07.004     Document Type: Article

References (50)

1. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Brain Res. Rev. 19:1994;1-28.
2. Antelman S.M., Eichler A.J., Black C.A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 207:1980;329-331.
3. Aulakh C.S., Hill J.L., Murphy D.L. Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs. Eur. J. Pharmacol. 240:1993;85-88.
4. Badiani A., Morano M.I., Akil H., Robinson T.E. Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine. Brain Res. 673:1995;13-24.
5. Bellinger L.L., Williams F.E., Bernardis L.L. Effect of hypophysectomy, thyroidectomy, castration and adrenalectomy on diurnal food and water intake in rats. Proc. Soc. Exp. Biol. Med. 161:1979;162-166.
6. Borowsky B., Kuhn C.M. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology. 31:1992;671-678.
7. Cador M., Cole B.J., Koob G.F., Stinus L., LeMoal M. Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res. 606:1993;181-186.
8. Canadian Council on Animal Care Guide to the Care and Use of Experimental Animals. vol. 2:1984;CCAC, Ontario.
9. Canadian Council on Animal Care Guide to the Care and Use of Experimental Animals. vol. 1:1993;CCAC, Ontario.
10. Cole B.J., Cador M., Stinus L., Rivier C., Rivier J., Vale W., Le Moal M., Koob G.F. Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci. 47:1990;1715-1720.
11. Coscina D.V., Currie P.J., Szechtman H. Association of altered whole-body metabolism with locomotor sensitization induced by quinpirole. Physiol. Behav. 63:1998;755-761.
12. Culver K.E., Szechtman H. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur. J. Pharmacol. 339:1997;109-111.
13. 2 receptors. Psychopharmacology. 167:2003;211-218.
14. Culver K.E., Rosenfeld J.M., Szechtman H. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology. 151:2000;202-210.
15. Culver K.E., Rosenfeld J.M., Szechtman H. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition. Neuropharmacology. 43:2002;385-393.
16. Deroche V., Piazza P.V., Maccari S., Le Moal M., Simon H. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res. 584:1992;309-313.
17. Deroche V., Piazza P.V., Casolini P., Macccari S., Le Moal M., Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res. 598:1992;343-348.
18. Deroche V., Marinelli M., Maccari S., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7181-7188.
19. DeVries T.J., Schoffelmeer A.N., Tjon G.H., Nestby P., Mulder A.H., Vanderschuren L.J. Mifepristone prevents the expression of long-term behavioral sensitization to amphetamine. Eur. J. Pharm. 307:1996;3-4.
20. Eilam D., Szechtman H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur. J. Pharm. 161:1989;151-157.
21. 2-agonist quinpirole induces preservation of routes and hyperactivity but no preservation of movements. Brain Res. 490:1989;255-267.
22. Franklin S.R., Tang A.H. Dopamine agonists facilitate footshock-elicited locomotion in rats, and suppress lever-press responding for food. Psychopharmacology. 121:1995;480-484.
23. Franklin S.R., Tang A.H. Quinpirole-induced locomotor stimulation in rats develops rapid sensitization when combined with brief footshocks. Behav. Pharmacol. 7:1996;94-100.
24. Goeders N.E. The HPA axis and cocaine reinforcement. Psychoneuroendocrinology. 27:2002;13-33.
25. Goeders N.E., Guerin G.F. Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology. 64:1996;337-348.
26. Hahn D.W., Ishibashi T., Turner C.W. Effect of hypophysectomy on feed intake in rats. Proc. Soc. Exp. Biol. Med. 119:1965;1238-1241.
27. Herman J.P., Stinus L., LeMoal M. Repeated stress increases locomotor response to amphetamine. Psychopharmacology. 84:1984;431-435.
28. Holzbauer M., Youdim M.B.H. Specific changes in type A and B monoamine oxidase activity in different tissues of hypophysectomized rats. Biochem. Pharmacol. 32:1983;469-473.
29. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Behav. Pharmacol. 4:1991;315-334.
30. 3H]quinpirole binding in rat striatal membranes. Eur. J. Pharmacol. 246:1993;171-178.
31. 3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site. J. Pharm. Exp. Ther. 278:1996;145-153.
32. A-deficient mice. Life Sci. 70:2001;229-241.
33. Lucas L.R., Schlussman S.D., Ho A., McEwen B.S., Kreek M.J. Novelty-induced locomotor activity in Long Evans rats pre- and post-chronic 'binge'-pattern cocaine treatment. Neurosci. Lett. 237:1997;25-28.
34. Marinelli M., Piazza P.V., Deroche V., Maccari S., Le Moal M., Simon H. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J. Neurosci. 14:1994;2724-2731.
35. Pauly J.R., Robinson S.F., Collins A.C. Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice. Brain Res. 620:1993;195-202.
36. Piazza P.V., Marinelli M., Jodogne C., Deroche V., Rouge-Pont F., Macccari S., Le Moal M., Simon H. Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 658:1994;259-264.
37. Piazza P.V., Marinelli M., Rouge-Pont F., Deroche V., Maccari S., Simon H., LeMoal M. Stress, glucocorticoids and mesencephalic dopaminergic neurons: a pathophysiological chain determining vulnerability to psychostimulant abuse. NIDA Res. Monogr. 163:1996;277-299.
38. Prasad B.M., Ulibarri C., Kalivas P.W., Sorg B.A. Effect of adrenalectomy on the initiation and expression of cocaine-induced sensitization. Psychopharmacology. 125:1996;265-273.
39. Przegalinski E., Filip M., Siwanowiz J., Nowak E. Effect of adrenalectomy and corticosterone on cocaine-induced sensitization in rats. J. Physiol. Pharmacol. 51:2000;193-204.
40. Rivet J.M., Stimus L., Le Moal M., Mormede N. Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res. 498:1989;149-153.
41. Robinson T.E., Becker J.B. Enduring change in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396:1986;157-198.
42. Rouge-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. II. Sensitization of the increases in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7189-7195.
43. Segal D.S., Schuckit M.A. Animal models of stimulant-induced psychosis. Creese A. Stimulants: Neurochemical, Behavioral and Clinical Perspectives. 1983;131-167 Raven Press, New York.
44. Szechtman H., Dai H., Mustafa S., Einat H., Sullivan R.M. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole. Pharmacol. Biochem. Behav. 48:1994;921-928.
45. Szechtman H., Talangbayan H., Canaran G., Dai H., Eilam D. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy mechanism. Psychopharmacology. 115:1994;95-104.
46. Szechtman H., Sulis W., Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive compulsive disorder (OCD). Behav. Neurosci. 112:1998;1475-1785.
47. Szechtman H., Culver K.E., Eilam D. Role of dopamine systems in obsessive-compulsive disorder: implications from a novel psychostimulant- induced animal model. Pol. J. Pharm. 51:1999;55-61.
48. Szumlinski K.K., Allan M., Talangbayan H., Tracey A., Szechtman H. Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency. Psychopharmacology. 134:1997;193-200.
49. Ventura M.A. Effects of clorgyline and deprenil on corticosterone levels in rats. Eur. J. Pharm. 81:1982;349-355.
50. Youdim M.B.H., Holzbauer M. Physiological and pathological changes in tissue monoamine oxidase activity. J. Neural Transm. 38:1976;193-229.